» Articles » PMID: 21602279

Random Mutagenesis of the Proton-coupled Folate Transporter (SLC46A1), Clustering of Mutations, and the Bases for Associated Losses of Function

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2011 May 24
PMID 21602279
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Loss-of-function mutations in the proton-coupled folate transporter (PCFT, SLC46A1) result in the autosomal recessive disorder, hereditary folate malabsorption (HFM). Identification and characterization of HFM mutations provide a wealth of information on the structure-function relationship of this transporter. In the current study, PCR-based random mutagenesis was employed to generate unbiased loss-of-function mutations of PCFT, simulating the spectrum of alterations that might occur in the human disorder. A total of 26 mutations were generated and 4 were identical to HFM mutations. Eleven were base deletion or insertion mutations that led to a frameshift and, along with similar HFM mutations, are predominantly localized to two narrow regions of the pcft gene at the 5'-end. Base substitution mutations identified in the current study and HFM patients were largely distributed across the pcft gene. Elimination of the ATG initiation codon by a one-base substitution (G > A) did not result in a complete lack of translation at the same codon consistent with rare non-ATG translation initiation. Among six missense mutants evaluated, three mutant PCFTs were not detected at the plasma membrane, one mutation resulted in decreased binding to folate substrate, and one had a reduced rate of conformational change associated with substrate translocation. The remaining PCFT mutant had defects in both processes. These results broaden understanding of the regions of the pcft gene prone to base insertion and deletion and inform further approaches to the analysis of the structure-function of PCFT.

Citing Articles

Biology and therapeutic applications of the proton-coupled folate transporter.

Matherly L, Schneider M, Gangjee A, Hou Z Expert Opin Drug Metab Toxicol. 2022; 18(10):695-706.

PMID: 36239195 PMC: 9637735. DOI: 10.1080/17425255.2022.2136071.


The evolving biology of the proton-coupled folate transporter: New insights into regulation, structure, and mechanism.

Hou Z, Gangjee A, Matherly L FASEB J. 2022; 36(2):e22164.

PMID: 35061292 PMC: 8978580. DOI: 10.1096/fj.202101704R.


The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.

Matherly L, Hou Z, Gangjee A Cancer Chemother Pharmacol. 2017; 81(1):1-15.

PMID: 29127457 PMC: 5756103. DOI: 10.1007/s00280-017-3473-8.


Role of the tryptophan residues in proton-coupled folate transporter (PCFT-SLC46A1) function.

Najmi M, Zhao R, Fiser A, Goldman I Am J Physiol Cell Physiol. 2016; 311(1):C150-7.

PMID: 27251438 PMC: 4967132. DOI: 10.1152/ajpcell.00084.2016.


Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB.

Schuster S, Vavra M, Kern W Antimicrob Agents Chemother. 2016; 60(7):4315-23.

PMID: 27161641 PMC: 4914648. DOI: 10.1128/AAC.00314-16.


References
1.
Meyer E, Kurian M, Pasha S, Trembath R, Cole T, Maher E . A novel PCFT gene mutation (p.Cys66LeufsX99) causing hereditary folate malabsorption. Mol Genet Metab. 2009; 99(3):325-8. PMC: 2852677. DOI: 10.1016/j.ymgme.2009.11.004. View

2.
Shin D, Min S, Russell L, Zhao R, Fiser A, Goldman I . Functional roles of aspartate residues of the proton-coupled folate transporter (PCFT-SLC46A1); a D156Y mutation causing hereditary folate malabsorption. Blood. 2010; 116(24):5162-9. PMC: 3012536. DOI: 10.1182/blood-2010-06-291237. View

3.
Unal E, Zhao R, Chang M, Fiser A, Romero M, Goldman I . The functional roles of the His247 and His281 residues in folate and proton translocation mediated by the human proton-coupled folate transporter SLC46A1. J Biol Chem. 2009; 284(26):17846-57. PMC: 2719423. DOI: 10.1074/jbc.M109.008060. View

4.
Borzutzky A, Crompton B, Bergmann A, Giliani S, Baxi S, Martin M . Reversible severe combined immunodeficiency phenotype secondary to a mutation of the proton-coupled folate transporter. Clin Immunol. 2009; 133(3):287-94. PMC: 2783538. DOI: 10.1016/j.clim.2009.08.006. View

5.
Shibagaki N, Grossman A . The role of the STAS domain in the function and biogenesis of a sulfate transporter as probed by random mutagenesis. J Biol Chem. 2006; 281(32):22964-73. DOI: 10.1074/jbc.M603462200. View